
CGM: Is “More” always better? Abbott’s Libres. More Data – part 1
Abbot – More data In the first part of this series, we looked at Dexcom, it’s claims of greater accuracy, and what benefit that provided. […]
Abbot – More data In the first part of this series, we looked at Dexcom, it’s claims of greater accuracy, and what benefit that provided. […]
Over the past few years we’ve seen a number of the larger CGM manufacturers allowing us to infer that their newer products are better because […]
With performance numbers on the new 15-day, prescription free, Stelo sensor from Dexcom looking very similar to those from the G7, could Dexcom be contemplating the announcement of an uldated 15-day iCGM at EASD in Madrid?
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
Those who keep an eye on diabetes technology conferences will know that Roche are running an industry symposium at ATTD (Advanced Technology and Treatments for […]
If you have type 1 and use social media, you can’t have missed the adverts for the newly CE marked SiBionics GS1 CGM system. They […]
With the recent ascent of the SiBionics CGM system to CE mark and the introduction of an updated Medtrum Nano CGM system, it’s about time […]
A new CGM system, brought to you by Sibionics, who also released the world’s first Continuous Ketone Monitor. Whilst it remains non-CE marked, they’ve been giving it away via social media viral marketing.
These are my first impressions.
As we have espoused here on Diabettech in the past, not all clinical trials for CGM systems are equal. To this, end, we’re now proud […]
Having tested a G7 against the Libre3, and found that without calibration, it tended to produce results that I wasn’t satisfied with using just the […]
Copyright © 2025 | WordPress Theme by MH Themes